AI Article Synopsis

  • The study identified high levels of MCF2L in hepatocellular carcinoma (HCC) tissues, suggesting it plays a role in resistance to sorafenib, a common cancer treatment.
  • Various experiments confirmed that reducing MCF2L levels increased cell death when treated with sorafenib, and that this process is linked to ferroptosis, a specific type of cell death.
  • The research also indicated that MCF2L influences the PI3K/AKT signaling pathway via a RhoA/Rac1-dependent mechanism, making it a potential target for overcoming treatment resistance in HCC.

Article Abstract

Methods And Results: The levels of MCF2L were detected by PCR and western blotting assay. The effect of MCF2L on ferroptosis was confirmed by MTT, colony formation assay, Brdu, in vivo animal experiment, and the content of Iron, GSH, ROS, and MDA. The underlying mechanisms were explored by PCR, western blotting, and affinity precipitation assay. Our findings demonstrated that MCF2L is remarkedly upregulated in HCC tissues, and sorafenib can induce the levels of MCF2L, suggesting that MCF2L might function in sorafenib resistance of HCC. Further analysis showed that downregulation of MCF2L enhances HCC cell death induced by sorafenib, and ferroptosis inhibitor can reverse this process. Subsequent experiments showed that downregulation of MCF2L elevates the content of Iron, ROS, and MDA, which are all indicators of ferroptosis. Finally, mechanism analysis showed that MCF2L regulates the PI3K/AKT pathway in a RhoA/Rac1 dependent manner.

Conclusions: Our study showed that targeting MCF2L may be a hopeful method to overcome sorafenib-resistance through inducing ferroptosis in HCC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626212PMC
http://dx.doi.org/10.1155/2022/6138941DOI Listing

Publication Analysis

Top Keywords

downregulation mcf2l
12
mcf2l
9
pathway rhoa/rac1
8
rhoa/rac1 dependent
8
levels mcf2l
8
pcr western
8
western blotting
8
content iron
8
ros mda
8
ferroptosis
5

Similar Publications

Article Synopsis
  • The study identified high levels of MCF2L in hepatocellular carcinoma (HCC) tissues, suggesting it plays a role in resistance to sorafenib, a common cancer treatment.
  • Various experiments confirmed that reducing MCF2L levels increased cell death when treated with sorafenib, and that this process is linked to ferroptosis, a specific type of cell death.
  • The research also indicated that MCF2L influences the PI3K/AKT signaling pathway via a RhoA/Rac1-dependent mechanism, making it a potential target for overcoming treatment resistance in HCC.
View Article and Find Full Text PDF

The roles of long noncoding RNA (lncRNA) MCF2L-AS1 have been identified in colorectal cancer, however, its roles in lung cancer progression have never been revealed. Here, we found that lncRNA MCF2L-AS1 was highly expressed in lung cancer tissues and cells, especially in non-small cell lung cancer (NSCLC). Functional experiments showed that MCF2L-AS1 knockdown suppressed the cancer stem cell (CSC)-like traits of NSCLC cells through qRT-PCR, western blot, tumor-sphere formation, and ALDH activity detection.

View Article and Find Full Text PDF

Objective: to establish the connection of radiation-induced changes in gene expression with the realized pathology of the broncho-pulmonary and cardiovascular systems in Chornobyl clean-up workers.

Materials And Methods: We examined 314 male Chornobyl clean-up workers (main group; age (58.94 ± 6.

View Article and Find Full Text PDF

LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.

Carcinogenesis

February 2021

Department of General Surgery, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, PR China.

Long non-coding RNAs (lncRNAs) regulate a series of biological processes, and their anomalous expression exerts critical roles in progression of multiple malignancies, including colorectal cancer (CRC). The present study was designed to provide new ideas and perspectives for the role of lncRNA MCF2L-AS1 and disclose the underlying mechanism in CRC. Herein, we observed that MCF2L-AS1 expression was enriched in CRC tissues and cell lines.

View Article and Find Full Text PDF

Bone homeostasis is maintained by balanced osteoblast-mediated tissue production and osteoclast-mediated tissue destruction, and is disrupted in pathological conditions such as osteoporosis. The mechanisms underlying osteogenic differentiation of bone marrow mesenchymal stem cells, which is critical to bone homeostasis, are not completely clear, despite extensively studies. Long noncoding RNAs (lncRNAs) have recently emerged as novel therapeutic targets in various diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!